Loading...
Cochlear Limited
CHEOF•PNK
Healthcare
Medical - Devices
$202.69
$0.00(0.00%)
Cochlear Limited (CHEOF) Financial Performance & Income Statement Overview
Review Cochlear Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
15.47%
↑ 15.47%
Operating Income Growth
26.45%
↑ 26.45%
Net Income Growth
18.70%
↑ 18.70%
Operating Cash Flow Growth
7.28%
↑ 7.28%
Operating Margin
21.70%
↑ 21.70%
Gross Margin
75.02%
↑ 75.02%
Net Profit Margin
15.85%
↑ 15.85%
ROE
19.70%
↑ 19.70%
ROIC
23.11%
↑ 23.11%
Cochlear Limited (CHEOF) Income Statement & Financial Overview
Review Cochlear Limited's (CHEOF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $383.10M | $513.60M | $485.20M | $555.50M |
| Short Term Investments | $0.00 | $102.70M | $0.00 | $0.00 |
| Cash & Short Term Investments | $383.10M | $513.60M | $485.20M | $555.50M |
| Net Receivables | $501.60M | $490.70M | $379.30M | $457.50M |
| Inventory | $461.10M | $391.60M | $321.50M | $311.50M |
| Other Current Assets | $64.80M | $44.90M | $66.90M | $37.00M |
| Total Current Assets | $1.41B | $1.45B | $1.33B | $1.36B |
| Property Plant & Equipment (Net) | $537.60M | $517.20M | $455.90M | $447.20M |
| Goodwill | $0.00 | $257.70M | $0.00 | $256.10M |
| Intangible Assets | $467.80M | $193.30M | $458.70M | $444.10M |
| Goodwill & Intangible Assets | $467.80M | $451.00M | $458.70M | $700.20M |
| Long Term Investments | $198.90M | $83.40M | $161.30M | $190.60M |
| Tax Assets | $0.00 | $138.70M | $127.20M | $125.30M |
| Other Non-Current Assets | $171.20M | $102.70M | $0.00 | -$256.10M |
| Total Non-Current Assets | $1.38B | $1.29B | $1.20B | $1.21B |
| Total Assets | $2.79B | $2.75B | $2.53B | $2.57B |
| Account Payables | $285.50M | $303.20M | $247.10M | $270.40M |
| Short Term Debt | $43.10M | $41.60M | $39.80M | $39.20M |
| Tax Payables | $0.00 | $17.60M | $21.30M | $17.50M |
| Deferred Revenue | $0.00 | $66.70M | $69.80M | $61.60M |
| Other Current Liabilities | $297.50M | $202.40M | $139.40M | $189.30M |
| Total Current Liabilities | $626.10M | $631.50M | $517.40M | $578.00M |
| Long Term Debt | $203.50M | $202.10M | $333.80M | $162.60M |
| Deferred Revenue Non-Current | $0.00 | $8.60M | $8.60M | $9.80M |
| Deferred Tax Liabilities Non-Current | $0.00 | $18.90M | $17.40M | $18.30M |
| Other Non-Current Liabilities | $88.90M | $43.50M | -$102.50M | $51.20M |
| Total Non-Current Liabilities | $292.40M | $273.10M | $231.30M | $241.90M |
| Capital Lease Obligations | $246.60M | $243.70M | $166.90M | $162.60M |
| Total Liabilities | $918.50M | $904.60M | $748.70M | $819.90M |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $1.19B | $1.20B | $1.20B | $1.25B |
| Retained Earnings | $735.50M | $667.90M | $632.10M | $555.40M |
| Accumulated Other Comprehensive Income/Loss | -$52.90M | -$31.60M | -$54.50M | -$56.90M |
| Total Stockholders Equity | $1.87B | $1.84B | $1.78B | $1.75B |
| Total Equity | $1.87B | $1.84B | $1.78B | $1.75B |
| Total Liabilities & Stockholders Equity | $2.79B | $2.75B | $2.53B | $2.57B |
| Total Investments | $198.90M | $186.10M | $161.30M | $190.60M |
| Total Debt | $246.60M | $243.70M | $206.70M | $201.80M |
| Net Debt | -$136.50M | -$269.90M | -$278.50M | -$353.70M |
Cochlear Limited (CHEOF) Balance Sheet Analysis
Cochlear Limited (CHEOF) manages its money wisely, with plenty of 7.28% and 18.70% to cover its bills. The company’s long-term debts are N/A, balanced by steady 15.85%. Shareholders’ stake in the business has grown thanks to smart decisions. Overall, the numbers show a solid position, giving it room to invest, expand, or adapt. For investors, this paints a promising picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan